Aberrant methylation patterns in colorectal cancer: a meta-analysis

Area of Science:

• Molecular Oncology
• Epigenetics
• Systems Medicine

Background:

• Colorectal cancer (CRC) is a major global health concern with complex, incompletely understood molecular underpinnings.
• DNA methylation profiles offer stable biomarkers for investigating CRC onset and progression.
• Understanding these epigenetic changes is crucial for identifying potential drivers, markers, and therapeutic targets in CRC.

Purpose of the Study:

• To conduct a meta-analysis of DNA methylation datasets from normal, adenoma (ADE), and adenocarcinoma (CRC) tissues.
• To identify tumor gene episignatures associated with colorectal cancer development.
• To validate the findings in an independent cohort, such as The Cancer Genome Atlas (TCGA).

Main Methods:

• Meta-analysis of Illumina 450k array DNA methylation data from normal, ADE, and CRC samples.
• Application of a differential meta-analysis pipeline for identifying methylation profile changes.
• Network reconstruction, topological, and functional analyses to pinpoint key epigenomic features.

Main Results:

• Identified differentially methylated genes across normal, ADE, and CRC samples.
• Confirmed that genes with known genetic or transcriptional alterations in CRC also exhibit differential methylation.
• Highlighted specific epigenomic features relevant to colorectal cancer tumorigenesis.

Conclusions:

• Epigenetic alterations, specifically DNA methylation, play a significant role in colorectal cancer development.
• The identified tumor gene episignatures reinforce the involvement of specific genes in CRC tumorigenesis, irrespective of the cellular control level.
• These findings provide a validated list of potential drivers, markers, and targets for colorectal cancer research and treatment.